FDA Approvals

Date Posted
Article Title
1/28/2016
Halaven Approved for Advanced Soft Tissue Cancer

FDA says it's first liposarcoma drug to improve survival

1/18/2016
FDA Approves Redesign of Endoscope Tied to Infections

Olympus TJF-Q180V duodenoscope had been linked to serious infections, but redesign should lower the risk

1/7/2016
Device Approved for Diabetic Foot Ulcers

Wounds lead to thousands of amputations annually

12/23/2015
Zurampic Approved for Gout

Drug helps control blood levels of uric acid

12/22/2015
Uptravi Approved for Chronic Lung Disease

Pulmonary arterial hypertension

12/18/2015
New Device Approved for Fecal Incontinence

Inability to control bowels often stems from muscle damage

12/17/2015
LifeVest Wearable Defibrillator Approved for Children

For heart patients who can't have device implanted

12/15/2015
Bridion Approved to Reverse Effects of Surgical Drugs

Medications used during surgery to paralyze vocal chords

12/11/2015
Alecensa Approved for Lung Cancer Tied to Gene Mutation

Drug to be used for ALK-positive non-small cell lung cancers

12/11/2015
Vistogard Approved for Chemotherapy Overdose

For drugs often prescribed to treat breast, colon cancers

12/9/2015
Cooling Cap to Reduce Chemo-Linked Hair Loss OK'd

Designed for women diagnosed with breast cancer

12/8/2015
Vonvendi Approved to Control Bleeding Disorder

Clotting factor sanctioned for von Willebrand disease

12/8/2015
Kanuma Approved for Rare Missing-Enzyme Disease

Wolman disease triggers fat buildup, leading to heart and liver problems

11/30/2015
Empliciti Approved for Multiple Myeloma

Drug boosts immune system to destroy cancer cells

11/24/2015
Portrazza Approved for Advanced Lung Cancer

The top cause of cancer death in the United States

11/24/2015
Opdivo Approved for Advanced Kidney Cancer

More than 14,000 projected to die from disease this year

11/24/2015
Anthrax Vaccine Approval Expanded

Now sanctioned for adults 18 to 65 with known or suspected exposure

11/20/2015
Ninlaro Approved for Multiple Myeloma

Blocks certain enzymes, hindering cancer-cell growth

11/19/2015
Narcan Nasal Spray Approved to Counter Narcotic Painkiller Overdose

First-of-its-kind drug sanctioned to reverse effects of heroin or oxycodone use

11/16/2015
Darzalex Approved for Multiple Myeloma

For people who have received other treatments